ReviewRMD open2026
Cellular and molecular basis of neuropathic pain.
Review in RMD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Neuropathic pain is a devastating type of pain that significantly reduces the quality of life of affected people. Traditionally considered as mechanistically distinct from pain induced by classical inflammatory states, studies continue to reveal more commonalities than differences, with a whole host of pathological changes in the environment of local peripheral nerves accompanying chronic neuropathic pain conditions. This narrative review provides an overview of the cellular and molecular drivers of neuropathic pain, highlighting some of the seminal publications from past and present. We discuss both neuronal and non-neuronal mechanisms contributing to neuropathic pain (eg, immune and stromal cell dysregulation). Particular attention is given to studies involving human cohorts which, until recently, have been less common in the field, due to the difficulties in accessing relevant tissues, like nervous system samples. The consequences of recent findings for analgesic drug development are also discussed, both in the context of neuropathic and non-neuropathic pain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.